Koers Univo Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE
Aandelen
UNVO
IL0010935588
Biotechnologie & Medisch Onderzoek
Omzet 2019 | 0,82 3,1 0,76 | Omzet 2020 | 33,68 126,55 31,19 | Marktkapitalisatie | 75,1 mln. 282 mln. 69,54 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -11 mln. -41,33 mln. -10,19 mln. | Nettowinst (verlies) 2020 | - 0 0 | EV/omzet 2019 | 35.543.010 x |
Nettoliquiditeiten 2019 | 22,82 mln. 85,75 mln. 21,13 mln. | Nettoschuld 2020 | 4,12 mln. 15,48 mln. 3,81 mln. | EV/omzet 2020 | 2.352.105 x |
K/w-verhouding 2019 * |
-
| K/w-verhouding 2020 |
-
| Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 59,28% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 48 | 04-04-93 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 64 | 15-07-19 |
Golan Bitton
CEO | Chief Executive Officer | 48 | 04-04-93 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,85% | 57,87 mld. | |
+41,42% | 40,25 mld. | |
-5,25% | 39,94 mld. | |
-5,16% | 28,54 mld. | |
+12,79% | 26,4 mld. | |
-20,18% | 19,33 mld. | |
+30,88% | 12,4 mld. | |
+0,61% | 12,23 mld. | |
+25,06% | 12,2 mld. |